Live feed09:00:49·1675dSECFilingvia QuantisnowVivos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership UpdateByQuantisnow·Wall Street's wire, on your screen.VVOS· Vivos Therapeutics Inc.Health CareOriginal source